Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 9 filers reported holding Astellas Pharma Inc in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $264,362 | +58.5% | 19,087 | +70.1% | 0.00% | +100.0% |
| Q2 2023 | $166,834 | +5.6% | 11,221 | +6.5% | 0.00% | -75.0% |
| Q1 2019 | $158,000 | +4.6% | 10,534 | -11.1% | 0.01% | -11.1% |
| Q4 2018 | $151,000 | -27.1% | 11,853 | 0.0% | 0.01% | -18.2% |
| Q3 2018 | $207,000 | +3.5% | 11,853 | -9.7% | 0.01% | 0.0% |
| Q2 2018 | $200,000 | +0.5% | 13,126 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $199,000 | +19.2% | 13,126 | 0.0% | 0.01% | +22.2% |
| Q4 2017 | $167,000 | – | 13,126 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RENAISSANCE GROUP LLC | 391,745 | $5,438,880 | 0.25% |
| Cassady Schiller Wealth Management, LLC | 698 | $9,667 | 0.01% |
| MAI Capital Management | 19,087 | $264,362 | 0.00% |
| SVB WEALTH LLC | 10,472 | $145,037 | 0.00% |
| RHUMBLINE ADVISERS | 34,759 | $481,408 | 0.00% |
| First Horizon Advisors, Inc. | 114 | $1,578 | 0.00% |
| Operose Advisors LLC | 90 | $1,247 | 0.00% |
| Russell Investments Group, Ltd. | 783 | $10,845 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 166 | $2,299 | 0.00% |